Deepak Bhatt, Cleveland Clinic, Ohio
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The idea of adding clopidogrel anti-platelet therapy to standard aspirin therapy among patients with multiple risk factors for coronary disease is not supported by